Kemeny N - Search Results

1

5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.

Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. Fata F, et al. Among authors: kemeny n. Cancer. 1999 Oct 1;86(7):1129-34. doi: 10.1002/(sici)1097-0142(19991001)86:7<1129::aid-cncr5>3.0.co;2-4. Cancer. 1999. PMID: 10506695

2

A randomized study of two different schedules of methyl CCNU, 5-FU and vincristine for metastatic colorectal carcinoma.

Kemeny N, Yagoda A, Braun D Jr, Golbey R. Kemeny N, et al. Cancer. 1979 Jan;43(1):78-82. doi: 10.1002/1097-0142(197901)43:1<78::aid-cncr2820430111>3.0.co;2-h. Cancer. 1979. PMID: 367575 Clinical Trial.

3

A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, Botet J, Oderman P, Murray P. Kemeny N, et al. Cancer. 1992 Jan 15;69(2):327-34. doi: 10.1002/1097-0142(19920115)69:2<327::aid-cncr2820690209>3.0.co;2-u. Cancer. 1992. PMID: 1303612 Clinical Trial.

4

Type Ia glycogenosis associated with hepatocellular carcinoma.

Conti JA, Kemeny N. Conti JA, et al. Among authors: kemeny n. Cancer. 1992 Mar 15;69(6):1320-2. doi: 10.1002/1097-0142(19920315)69:6<1320::aid-cncr2820690603>3.0.co;2-d. Cancer. 1992. PMID: 1311620 Review.

5

Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience.

Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Smith JW, et al. Among authors: kemeny n. Cancer. 1992 Jul 15;70(2):396-401. doi: 10.1002/1097-0142(19920715)70:2<396::aid-cncr2820700205>3.0.co;2-a. Cancer. 1992. PMID: 1319813

6

Treatment of unresectable primary liver cancer with intrahepatic fluorodeoxyuridine and mitomycin C through an implantable pump.

Atiq OT, Kemeny N, Niedzwiecki D, Botet J. Atiq OT, et al. Among authors: kemeny n. Cancer. 1992 Feb 15;69(4):920-4. doi: 10.1002/1097-0142(19920215)69:4<920::aid-cncr2820690414>3.0.co;2-y. Cancer. 1992. PMID: 1370918

7

Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.

O'Boyle KP, Zamore R, Adluri S, Cohen A, Kemeny N, Welt S, Lloyd KO, Oettgen HF, Old LJ, Livingston PO. O'Boyle KP, et al. Among authors: kemeny n. Cancer Res. 1992 Oct 15;52(20):5663-7. Cancer Res. 1992. PMID: 1394190

8

Review of regional therapy of liver metastases in colorectal cancer.

Kemeny N. Kemeny N. Semin Oncol. 1992 Apr;19(2 Suppl 3):155-62. Semin Oncol. 1992. PMID: 1532670 Review.

9

Alfa-2A interferon and 5-fluorouracil for advanced colorectal carcinoma: the Memorial Sloan-Kettering experience.

Kemeny N, Younes A. Kemeny N, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):171-5. Semin Oncol. 1992. PMID: 1557642 Clinical Trial.

10

Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.

Kemeny N, Conti JA, Seiter K, Niedzwiecki D, Botet J, Martin D, Costa P, Wiseberg J, McCulloch W. Kemeny N, et al. J Clin Oncol. 1992 May;10(5):747-52. doi: 10.1200/JCO.1992.10.5.747. J Clin Oncol. 1992. PMID: 1569447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters